Sequent Scientific Limited has approved the appointment of Mr. Ramakant Singani as Chief Financial Officer and Key Managerial Personnel of the Company with effect from January 1, 2026, as recommended by Nomination and Remuneration Committee and Audit committee and approved by the Board. Mr. Ramakant Singani has 31 years of experience across all aspects of finance including Business Finance, Accounting, Financial planning and analysis, ERP implementation and cost management. He has been Chief Financial Officer of Viyash since September 2021.
Prior to joining Viyash, he was Head of GMO Finance at Dr. Reddy?s. SeQuent Scientific Limited has noted the resignation of Mr. Saurav Bhala as Chief Financial Officer and Key Managerial Personnel of the Company with effect from January 01, 2026.
